New implications for the QUAKING RNA binding protein in human disease

Journal of Neuroscience Research

Volumn 86, Issue 2, 2008, Pages 233-242

  Chénard, Carol Anne ^b   Richard, Stéphane ^a  

^a MCGILL UNIVERSITY   (Canada)

^b NONE

Author keywords

Glioblastoma; KH domain; Myelination; Schizophrenia; Vascular remodeling

Indexed keywords

ETHYLNITROSOUREA; MYELIN; PROTEIN; RNA BINDING PROTEIN;

ANGIOGENESIS; APOPTOSIS; ATAXIA; CELL FATE; CELL FUNCTION; EMBRYO DEVELOPMENT; GENETIC ORGANIZATION; GLIA CELL; GLIOBLASTOMA; HUMAN; MUTATION; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; RNA BINDING; RNA SPLICING; RNA TRANSLATION; SCHIZOPHRENIA;

ANIMALS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; HUMANS; MICE; MICE, QUAKING; PROTEIN ISOFORMS; RNA-BINDING PROTEINS; SCHIZOPHRENIA;

EID: 38849206330     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21485     Document Type: Review

References (87)

1. Aberg K, Saetre P, Jareborg N, Jazin E. 2006a. Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc Natl Acad Sci U S A 103:7482-7487.
2. Aberg K, Saetre P, Lindholm E, Ekholm B, Pettersson U, Adolfsson R, Jazin E. 2006b. Human QKI, a new candidate gene for schizophrenia involved in myelination. Am J Med Genet B Neuropsychiatr Genet 141:84-90.
3. Baehrecke EH. 1997. Who encodes a KH RNA binding protein that functions in muscle development. Development 124:1323-1332.
4. Belda-Iniesta C, de Castro Carpeno J, Casado Saenz E, Cejas Guerrero P, Perona R, Gonzalez Baron M. 2006. Molecular biology of malignant gliomas. Clin Transl Oncol 8:635-641.
5. Bohnsack BL, Lai L, Northrop JL, Justice MJ, Hirschi KK. 2006. Visceral endoderm function is regulated by quaking and required for vascular development. Genesis 44:93-104.
6. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V Jr, Chao MV, Koff A. 1997. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11:2335-2346.
7. Chen T, Richard S. 1998. Structure-function analysis of Qk1: a lethal point mutation in mouse quaking prevents homodimerization. Mol Cell Biol 18:4863-4871.
8. Clifford R, Lee MH, Nayak S, Ohmachi M, Giorgini F, Schedl T. 2000. FOG-2, a novel F-box containing protein, associates with the GLD-1 RNA binding protein and directs male sex determination in the C. elegans hermaphrodite germline. Development 127:5265-5276.
9. Cote J, Boisvert FM, Boulanger MC, Bedford MT, Richard S. 2003. Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol Biol Cell 14:274-287.
10. Cox RD, Whittington J, Shedlovsky A, Connelly CS, Dove WF, Goldsworthy M, Larin Z, Lehrach H. 1993. Detailed physical and genetic mapping in the region of plasminogen, D17Rp17e, and quaking. Mamm Genome 4:687-694.
11. Cox RD, Shedlovsky A, Hamvas R, Goldsworthy M, Whittington J, Connelly CS, Dove WF, Lehrach H. 1994. A 1.2-Mb YAC contig spans the quaking region. Genomics 21:77-84.
12. Cox RD, Hugill A, Shedlovsky A, Noveroske JK, Best S, Justice MJ, Lehrach H, Dove WF. 1999. Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene. Genomics 57:333-341.
13. Darnell RB. 2004. Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol 61:30-32.
14. Draper BW, Mello CC, Bowerman B, Hardin J, Priess JR. 1996. MEX-3 is a KH domain protein that regulates blastomere identity in early C. elegans embryos. Cell 87:205-216.
15. Dreyfuss G, Kim VN, Kataoka N. 2002. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3:195-205.
16. Durand B, Raff M. 2000. A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays 22:64-71.
17. Durand B, Gao FB, Raff M. 1997. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317.
18. Dyer MA, Cepko CL. 2001. p27Kip1 and p57Kip2 regulate proliferation in distinct retinal progenitor cell populations. J Neurosci 21:4259-4271.
19. Ebersole TA, Chen Q, Justice MJ, Artzt K. 1996. The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet 12:260-265.
20. Edenfeld G, Volohonsky G, Krukkert K, Naffin E, Lammel U, Grimm A, Engelen D, Reuveny A, Volk T, Klambt C. 2006. The splicing factor crooked neck associates with the RNA-binding protein HOW to control glial cell maturation in Drosophila. Neuron 52:969-980.
21. Friessen AJ, Miskimins WK, Miskimins R. 1997. Cyclin-dependent kinase inhibitor p27kip1 is expressed at high levels in cells that express a myelinating phenotype. J Neurosci Res 50:373-382.
22. Galarneau A, Richard S. 2005. Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 12:691-698.
23. Hagerman RJ. 2006. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr 27:63-74.
24. Hardy RJ. 1998a. Molecular defects in the dysmyelinating mutant quaking. J Neurosci Res 51:417-422.
25. Hardy RJ. 1998b. QKI expression is regulated during neuron-glial cell fate decisions. J Neurosci Res 54:46-57.
26. Hardy RJ, Loushin CL, Friedrich VL Jr, Chen Q, Ebersole TA, Lazzarini RA, Artzt K. 1996. Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci 16:7941-7949.
27. Haroutunian V, Katsel P, Dracheva S, Davis KL. 2006. The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: down-regulated in multiple brain regions in schizophrenia. Am J Psychiatry 163:1834-1837.
28. Hogan E, Greenfield S. 1984. Animal models of genetic disorders of myelin. In: Morell P, editor. Myelin, 2nd ed. New York: Plenum Press. p 489-534.
29. Humbert S, Saudou F. 2006. The ataxia-ome: connecting disease proteins of the cerebellum. Cell 125:645-647.
30. Ichimura K, Mungall AJ, Fiegler H, Pearson DM, Dunham I, Carter NP, Collins VP. 2006. Small regions of overlapping deletions on 6q26 in human astrocytic tumours identified using chromosome 6 tile path array-CGH. Oncogene 25:1261-1271.
31. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, Bohme GA, Laville M, Pratt J, Corti O, Pradier L, Ret G, Joubert C, Periquet M, Araujo F, Negroni J, Casarejos MJ, Canals S, Solano R, Serrano A, Gallego E, Sanchez M, Denefle P, Benavides J, Tremp G, Rooney TA, Brice A, Garcia de Yebenes J. 2003. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12:2277-2291.
32. Jin P, Warren ST. 2003. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 28:152-158.
33. Justice MJ, Bode VC. 1988. Three ENU-induced alleles of the murine quaking locus are recessive embryonic lethal mutations. Genet Res 51:95-102.
34. Knobbe CB, Reifenberger G. 2003. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathol 13:507-518.
35. Kondo T, Furuta T, Mitsunaga K, Ebersole TA, Shichiri M, Wu J, Artzt K, Yamamura K, Abe K. 1999. Genomic organization and expression analysis of the mouse qkI locus. Mamm Genome 10:662-669.
36. Lakiza O, Frater L, Yoo Y, Villavicencio E, Walterhouse D, Goodwin EB, Iannaccone P. 2005. STAR proteins quaking-6 and GLD-1 regulate translation of the homologues GLI1 and tra-1 through a conserved RNA 3′UTR-based mechanism. Dev Biol 287:98-110.
37. Larocque D, Richard S. 2005. QUAKING KH domain proteins as regulators of glial cell fate and myelination. RNA Biol 2:37-40.
38. Larocque D, Pilotte J, Chen T, Cloutier F, Massie B, Pedraza L, Couture R, Lasko P, Almazan G, Richard S. 2002. Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 36:815-829.
39. Larocque D, Galarneau A, Liu HN, Scott M, Almazan G, Richard S. 2005. Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation. Nat Neurosci 8:27-33.
40. Lee MH, Schedl T. 2001. Identification of in vivo mRNA targets of GLD-1, a maxi-KH motif containing protein required for C. elegans germ cell development. Genes Dev 15:2408-2420.
41. Lee MH, Schedl T. 2004. Translation repression by GLD-1 protects its mRNA targets from nonsense-mediated mRNA decay in C. elegans. Genes Dev 18:1047-1059.
42. Lewis HA, Musunuru K, Jensen KB, Edo C, Chen H, Darnell RB, Burley SK. 2000. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell 100:323-332.
43. Li Z, Zhang Y, Li D, Feng Y. 2000. Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J Neurosci 20:4944-4953.
44. Li ZZ, Kondo T, Murata T, Ebersole TA, Nishi T, Tada K, Ushio Y, Yamamura K, Abe K. 2002. Expression of Hqk encoding a KH RNA binding protein is altered in human glioma. Jpn J Cancer Res 93:167-177.
45. Li Z, Takakura N, Oike Y, Imanaka T, Araki K, Suda T, Kaname T, Kondo T, Abe K, Yamamura K. 2003. Defective smooth muscle development in qkI-deficient mice. Dev Growth Differ 45:449-462.
46. Lim J, Hao T, Shaw C, Patel AJ, Szabo G, Rual JF, Fisk CJ, Li N, Smolyar A, Hill DE, Barabasi AL, Vidal M, Zoghbi HY. 2006. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125:801-814.
47. Liu L, Ichimura K, Pettersson EH, Goike HM, Collins VP. 2000. The complexity of the 7p12 amplicon in human astrocytic gliomas: detailed mapping of 246 tumors. J Neuropathol Exp Neurol 59:1087-1093.
48. Liu Z, Luyten I, Bottomley MJ, Messias AC, Houngninou-Molango S, Sprangers R, Zanier K, Kramer A, Sattler M. 2001. Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science 294:1098-1102.
49. Lo PC, Frasch M. 1997. A novel KH-domain protein mediates cell adhesion processes in Drosophila. Dev Biol 190:241-256.
50. Lockhart PJ, O'Farrell CA, Farrer MJ. 2004. It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG). Mov Disord 19:101-104.
51. Lorenzetti D, Antalffy B, Vogel H, Noveroske J, Armstrong D, Justice M. 2004a. The neurological mutant quaking (viable) is Parkin deficient. Mamm Genome 15:210-217.
52. Lorenzetti D, Bishop CE, Justice MJ. 2004b. Deletion of the Parkin coregulated gene causes male sterility in the quaking (viable) mouse mutant. Proc Natl Acad Sci U S A 101:8402-8407.
53. Lu Z, Zhang Y, Ku L, Wang H, Ahmadian A, Feng Y. 2003. The quakingviable mutation affects qkI mRNA expression specifically in myelin-producing cells of the nervous system. Nucleic Acids Res 31:4616-4624.
54. Maguire ML, Guler-Gane G, Nietlispach D, Raine AR, Zorn AM, Standart N, Broadhurst RW. 2005. Solution structure and backbone dynamics of the KH-QUA2 region of the Xenopus STAR/GSG quaking protein. J Mol Biol 348:265-279.
55. McCullumsmith RE, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis KL, Meador-Woodruff JH. 2007. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr Res 90:15-27.
56. Mezquita J, Pau M, Mezquita C. 1998. Four isoforms of the signal-transduction and RNA-binding protein QKI expressed during chicken spermatogenesis. Mol Reprod Dev 50:70-78.
57. Morrison SJ. 2001. Neuronal differentiation: proneural genes inhibit gliogenesis. Curr Biol 11:R349-R351.
58. Mulholland PJ, Fiegler H, Mazzanti C, Gorman P, Sasieni P, Adams J, Jones TA, Babbage JW, Vatcheva R, Ichimura K, East P, Poullikas C, Collins VP, Carter NP, Tomlinson IP, Sheer D. 2006. Genomic profiling identifies discrete deletions associated with translocations in glioblastoma multiforme. Cell Cycle 5:783-791.
59. Musco G, Stier G, Joseph C, Castiglione Morelli MA, Nilges M, Gibson TJ, Pastore A. 1996. Three-dimensional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell 85:237-245.
60. Nabel-Rosen H, Volohonsky G, Reuveny A, Zaidel-Bar R, Volk T. 2002. Two isoforms of the Drosophila RNA binding protein, how, act in opposing directions to regulate tendon cell differentiation. Dev Cell 2:183-193.
61. Noveroske JK, Lai L, Gaussin V, Northrop JL, Nakamura H, Hirschi KK, Justice MJ. 2002. Quaking is essential for blood vessel development. Genesis 32:218-230.
62. Noveroske JK, Hardy R, Dapper JD, Vogel H, Justice MJ. 2005. A new ENU-induced allele of mouse quaking causes severe CNS dysmyelination. Mamm Genome 16:672-682.
63. Philipp-Staheli J, Payne SR, Kemp CJ. 2001. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 264:148-168.
64. Pilotte J, Larocque D, Richard S. 2001. Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. Genes Dev 15:845-858.
65. Richard S, Torabi N, Franco GV, Tremblay GA, Chen T, Vogel G, Morel M, Cleroux P, Forget-Richard A, Komarova S, Tremblay ML, Li W, Li A, Gao YJ, Henderson JE. 2005. Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss. PLoS Genet 1:e74.
66. Rowitch DH. 2004. Glial specification in the vertebrate neural tube. Nat Rev Neurosci 5:409-419.
67. Ryder SP, Williamson JR. 2004. Specificity of the STAR/GSG domain protein Qk1: implications for the regulation of myelination. RNA 10:1449-1458.
68. Ryder SP, Frater LA, Abramovitz DL, Goodwin EB, Williamson JR. 2004. RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1. Nat Struct Mol Biol 11:20-28.
69. Saccomanno L, Loushin C, Jan E, Punkay E, Artzt K, Goodwin EB. 1999. The STAR protein QKI-6 is a translational repressor. Proc Natl Acad Sci U S A 96:12605-12610.
70. Sanai N, Alvarez-Buylla A, Berger MS. 2005. Neural stem cells and the origin of gliomas. N Engl J Med 353:811-822.
71. Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T. 2000. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 25:302-305.
72. Sidman RL, Dickie MM, Appel SH. 1964. Mutant mice (Quaking and Jimpy) with deficient myelination in the central nervous system. Science 144:309-311.
73. Smith DI, Zhu Y, McAvoy S, Kuhn R. 2006. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett 232:48-57.
74. Stewart DG, Davis KL. 2004. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. Int Rev Neurobiol 59:381-424.
75. Suzuki K, Zagoren JC. 1975. Focal axonal swelling in cerebellum of quaking mouse: light and electron microscopic studies. Brain Res 85:38-43.
76. Suzuki K, Zagoren JC. 1977. Quaking mouse: an ultrastructural study of the peripheral nerves. J Neurocytol 6:71-84.
77. Tanaka H, Abe K, Kim CH. 1997. Cloning and expression of the quaking gene in the zebrafish embryo. Mech Dev 69:209-213.
78. Tartaglia LA, Goeddel DV. 1992. Tumor necrosis factor receptor signaling. A dominant negative mutation suppresses the activation of the 55-kDa tumor necrosis factor receptor. J Biol Chem 267:4304-4307.
79. Vernet C, Artzt K. 1997. STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 13:479-484.
80. Wu J, Zhou L, Tonissen K, Tee R, Artzt K. 1999. The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm. J Biol Chem 274:29202-29210.
81. Wu JI, Reed RB, Grabowski PJ, Artzt K. 2002. Function of quaking in myelination: regulation of alternative splicing. Proc Natl Acad Sci U S A 99:4233-4238.
82. Yang YY, Yin GL, Darnell RB. 1998. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci U S A 95:13254-13259.
83. Zaffran S, Astier M, Gratecos D, Semeriva M. 1997. The held out wings (how) Drosophila gene encodes a putative RNA-binding protein involved in the control of muscular and cardiac activity. Development 124:2087-2098.
84. Zhang Y, Lu Z, Ku L, Chen Y, Wang H, Feng Y. 2003. Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J 22:1801-1810.
85. Zhao L, Tian D, Xia M, Macklin WB, Feng Y. 2006. Rescuing qkV dysmyelination by a single isoform of the selective RNA-binding protein QKI. J Neurosci 26:11278-11286.
86. Zorn AM, Grow M, Patterson KD, Ebersole TA, Chen Q, Artzt K, Krieg PA. 1997. Remarkable sequence conservation of transcripts encoding amphibian and mammalian homologues of quaking, a KH domain RNA-binding protein. Gene 188:199-206.
87. Zu Horste GM, Nave KA. 2006. Animal models of inherited neuropathies. Curr Opin Neurol 19:464-473.